Lloyd Advisory Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$280K Sell
1,113
-1,950
-64% -$420K 0.11% 96
2026
Q1
$666K Buy
3,063
+1,929
+170% +$428K 0.19% 56
2025
Q4
$259K Sell
1,134
-562
-33% -$128K 0.1% 88
2025
Q3
$393K Buy
1,696
+10
+0.6% +$2.04K 0.18% 53
2025
Q2
$313K Buy
1,686
+360
+27% +$66.9K 0.15% 67
2025
Q1
$278K Buy
1,326
+138
+12% +$26.8K 0.14% 74
2024
Q4
$211K Sell
1,188
-94
-7% -$17.3K 0.1% 96
2024
Q3
$253K Buy
+1,282
New +$239K 0.12% 83
2024
Q2
Sell
-8,550
Closed -$1.56M 95
2024
Q1
$1.56M Buy
8,550
+6,758
+377% +$1.16M 0.33% 43
2023
Q4
$278K Sell
1,792
-6,653
-79% -$970K 0.13% 94
2023
Q3
$1.26M Buy
+8,445
New +$1.24M 0.41% 48
2022
Q2
Sell
-2,329
Closed -$378K 69
2022
Q1
$378K Sell
2,329
-322
-12% -$46.8K 0.18% 54
2021
Q4
$359K Buy
2,651
+14
+0.5% +$1.65K 0.17% 53
2021
Q3
$284K Sell
2,637
-49
-2% -$5.6K 0.15% 53
2021
Q2
$303K Sell
2,686
-11
-0.4% -$1.24K 0.15% 53
2021
Q1
$292K Sell
2,697
-25
-0.9% -$2.67K 0.16% 44
2020
Q4
$292K Sell
2,722
-188
-6% -$18.1K 0.16% 37
2020
Q3
$255K Sell
2,910
-852
-23% -$80.2K 0.16% 40
2020
Q2
$369K Sell
3,762
-458
-11% -$40.3K 0.23% 31
2020
Q1
$322K Sell
4,220
-507
-11% -$43.2K 0.24% 34
2019
Q4
$419K Buy
+4,727
New +$392K 0.38% 32

Other funds holding ABBV

Lloyd Advisory Services's ABBV Position: Q2 2026 in Review

Lloyd Advisory Services reduced its AbbVie (ABBV) stake by 64% in Q2 2026, selling an estimated $420K and leaving 1,113 shares worth $280K. The position accounts for 0.11% of the portfolio, ranked #96.

Lloyd Advisory Services first reported a position in ABBV in Q4 2019 and has held it in 21 quarters since. The position peaked at $1.56M in Q1 2024. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Lloyd Advisory Services held 1,113 shares of AbbVie worth $280K as of Q2 2026.
  • Lloyd Advisory Services sold 1,950 AbbVie shares in Q2 2026, an estimated $420K.
  • AbbVie made up 0.11% of Lloyd Advisory Services's portfolio in Q2 2026, its #96 holding.
  • Lloyd Advisory Services first reported a position in AbbVie in Q4 2019 and has held it in 21 quarters since.
  • Lloyd Advisory Services's AbbVie position peaked at $1.56M in Q1 2024.
  • 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lloyd Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.